Compugen Ltd. Reports Q1 2025 Results
Ticker: CGEN · Form: 6-K · Filed: May 19, 2025 · CIK: 1119774
| Field | Detail |
|---|---|
| Company | Compugen Ltd (CGEN) |
| Form Type | 6-K |
| Filed Date | May 19, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-results, 6-K, reporting
TL;DR
Compugen dropped Q1 2025 earnings on 5/19.
AI Summary
Compugen Ltd. filed a Form 6-K on May 19, 2025, to report its first quarter 2025 financial results via a press release. The company, based in Holon, Israel, is in the biological products sector and operates under SEC file number 000-30902.
Why It Matters
This filing provides investors with the latest financial performance data for Compugen Ltd., crucial for assessing the company's current health and future prospects.
Risk Assessment
Risk Level: low — This is a routine financial reporting filing (6-K) and does not contain new material events or significant financial changes.
Key Players & Entities
- Compugen Ltd. (company) — Registrant
- May 19, 2025 (date) — Filing date and reporting date
- 2025 (date) — Reporting period (first quarter)
- 000-30902 (other) — SEC File Number
- 26 Harokmim Street (address) — Principal Executive Offices
- Holon, Israel (location) — Principal Executive Offices
FAQ
What type of report is Compugen Ltd. filing?
Compugen Ltd. is filing a Form 6-K, which is a Report of Foreign Private Issuer.
When was this report filed with the SEC?
This report was filed on May 19, 2025.
What information is being reported in this 6-K?
The 6-K reports Compugen Ltd.'s first quarter 2025 results, as detailed in a press release.
What is Compugen Ltd.'s SEC file number?
Compugen Ltd.'s SEC file number is 000-30902.
Where are Compugen Ltd.'s principal executive offices located?
Compugen Ltd.'s principal executive offices are located at 26 Harokmim Street, Holon, Israel.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on May 19, 2025 regarding COMPUGEN LTD (CGEN).